City Therapeutics annual operating margin
2024
2025
City Therapeutics's operating margin was −441.84% for fiscal 2025.
View full City Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −441.84% | +605.32 pp |
| 2024 | 2024-12-31 | −1,047.16% | — |
Between the periods ended 2024-12-31 and 2025-12-31, City Therapeutics's operating margin increased from −1,047.16% to −441.84%, a change of +605.32 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review City Therapeutics source filings ↗